483 Sun Pharmaceutical Industries Mar 2017

483 Sun Pharmaceutical Industries Mar 2017

Yvesna Blaise FDA, Parul Patel FDA$119.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries - Cranbury, NJ, United States facility and issued inspectional observations (via FDA 483) on 20 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Mar 2017
  • Location: Cranbury, United States
  • FEI: 3005551493
Add To Cart